These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 3843169)
1. [Immunological aspects of primary cancer of the lung]. Blasi A Arch Monaldi; 1985; 40(5-6):187-202. PubMed ID: 3843169 [No Abstract] [Full Text] [Related]
2. [Role of immunotherapy in the combined treatment of lung cancer]. Trapeznikov NN; Gorodilova VV; Babakova SV; Kadagidze ZG; Trakhtenberg AKh Vopr Onkol; 1982; 28(2):51-6. PubMed ID: 6278769 [No Abstract] [Full Text] [Related]
3. [Current trends in immunotherapy of tumors of the lung]. Crispano G; Toglia V; Tranchese D; Schettini R Arch Monaldi; 1983; 38(1-2):41-52. PubMed ID: 6675558 [No Abstract] [Full Text] [Related]
4. Keynote address on immunology and immunotherapy. Israel L Cancer Chemother Rep 3; 1973 Mar; 4(2):29-30. PubMed ID: 4729335 [No Abstract] [Full Text] [Related]
5. [Immunologic reactions in the course of lung cancer]. Szopiński J Pneumonol Alergol Pol; 1997; 65(5-6):391-8. PubMed ID: 9340070 [No Abstract] [Full Text] [Related]
7. Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer. Kakimi K; Nakajima J; Wada H Lung Cancer; 2009 Jul; 65(1):1-8. PubMed ID: 19062127 [TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of cancer in man. V. Studies of patients with primary and metastatic tumors of the lung. Humphrey LJ; Abbott O; Logan W; Murray DR; Hatcher CR Am Surg; 1972 Aug; 38(8):418-21. PubMed ID: 4114636 [No Abstract] [Full Text] [Related]
9. Aspects of the immunologic treatment of lung cancer. Alth G; Denck H; Fischer M; Karrer K; Kokron O; Korizek E; Micksche M; Ogris E; Reider C; Titscher R; Wrba H Cancer Chemother Rep 3; 1973 Mar; 4(2):271-4. PubMed ID: 4729328 [No Abstract] [Full Text] [Related]
10. [Effect of transfer factor on surgical treatment of primary lung cancer]. Yamaguchi Y Rinsho Kyobu Geka; 1981; 1(3):397-405. PubMed ID: 7052613 [No Abstract] [Full Text] [Related]
11. Non-specific immunostimulation in bronchogenic cancer. Israel L Scand J Respir Dis Suppl; 1974; 89():95-105. PubMed ID: 4370224 [No Abstract] [Full Text] [Related]
12. [Cellular immunity indices in lung cancer patients after surgical and combined treatment]. Kharchenko VP; Sutiagin AG; Danilova TS; Pankina VKh Sov Med; 1981; (10):33-6. PubMed ID: 7313772 [No Abstract] [Full Text] [Related]
14. Immunotherapy as related to lung cancer: a review. Hersh EM; Mavligit GM; Gutterman JU Semin Oncol; 1974 Sep; 1(3):273-8. PubMed ID: 4620434 [No Abstract] [Full Text] [Related]
15. Immunotherapy of lung cancer: a review. Takita H Int Adv Surg Oncol; 1983; 6():229-56. PubMed ID: 6192089 [No Abstract] [Full Text] [Related]
16. Tumor specific expression of survivin-2B in lung cancer as a novel target of immunotherapy. Ichiki Y; Hanagiri T; Takenoyama M; Baba T; Fukuyama T; Nagata Y; Mizukami M; So T; Sugaya M; Yasuda M; So T; Sugio K; Yasumoto K Lung Cancer; 2005 May; 48(2):281-9. PubMed ID: 15829330 [TBL] [Abstract][Full Text] [Related]
17. [The immunological monitoring of lung cancer patients and its prognostic importance]. Red'ko AA; SHamov VA; Dvaladze NA; Karaseva NA; Malygin AM; Kutushev FKh Vestn Khir Im I I Grek; 1992 Mar; 148(3):262-5. PubMed ID: 8594741 [No Abstract] [Full Text] [Related]
18. Expression and immunogenicity of a tumor-associated antigen, 90K/Mac-2 binding protein, in lung carcinoma. Ozaki Y; Kontani K; Hanaoka J; Chano T; Teramoto K; Tezuka N; Sawai S; Fujino S; Yoshiki T; Okabe H; Ohkubo I Cancer; 2002 Nov; 95(9):1954-62. PubMed ID: 12404290 [TBL] [Abstract][Full Text] [Related]
20. Immunogenic targets in non-small cell lung cancer: more is more. Gnjatic S Clin Cancer Res; 2005 Aug; 11(15):5331-2. PubMed ID: 16061843 [No Abstract] [Full Text] [Related] [Next] [New Search]